abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Holders of 5% or more of HQL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of abrdn Life Sciences Investors, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Trust Portfolios LP | 13G/A | 10.09%3.02M shares | +3.76 ppfrom 6.33% | Apr 28, 20252 filings | Mar 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on abrdn Life Sciences Investors, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 202612:37 PM ET | First Trust Portfolios LPand 2 others | 13G/A | 10.09%3.02M shares | +3.76 ppfrom 6.33% | Feb 28, 2026 | SEC |
| Feb 23, 20265:50 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 4.95%1.46M shares | −0.75 ppfrom 5.70%Below 5% | Feb 19, 2026 | SEC |
| Feb 11, 20266:53 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 5.70%1.69M shares | −1.07 ppfrom 6.77% | Feb 9, 2026 | SEC |
| Jan 8, 20264:42 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 6.77%2.00M shares | −1.11 ppfrom 7.88% | Jan 7, 2026 | SEC |
| Nov 24, 202511:36 AM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 7.88%2.27M shares | −1.08 ppfrom 8.96% | Nov 21, 2025 | SEC |
| Sep 26, 20251:17 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 8.96%2.59M shares | −1.37 ppfrom 10.33% | Sep 24, 2025 | SEC |
| Sep 3, 20254:58 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 10.33%2.98M shares | −1.03 ppfrom 11.36% | Aug 29, 2025 | SEC |
| Apr 28, 20259:41 AM ET | First Trust Portfolios LPand 2 others | 13G | 6.33%1.83M shares | New | Mar 31, 2025 | SEC |
| Apr 1, 20259:49 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 11.36%3.19M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell abrdn Life Sciences Investors shares.
No Form 144 notices for abrdn Life Sciences Investors are on file.